Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Disease Risk and Health Genetic Test Market by Type (Celiac Disease, Parkinson Disease, Alzheimer Disease, Other), By Application (Online, Offline) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Disease Risk and Health Genetic Test Market by Type (Celiac Disease, Parkinson Disease, Alzheimer Disease, Other), By Application (Online, Offline) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 286410 4200 Pharma & Healthcare 377 250 Pages 4.7 (46)
                                          

Market Overview:


The global disease risk and health genetic test market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of chronic diseases, technological advancements in disease risk and health genetic testing, and growing demand for personalized medicine. The global disease risk and health genetic test market by type is segmented into celiac disease, Parkinson’s disease, Alzheimer’s disease, other diseases. The celiac disease segment is expected to grow at the highest CAGR during the forecast period owing to the increasing incidence of gluten intolerance across the globe. The global Disease Risk & Health Genetic Test Market by application is segmented into online application and offline application. The online application segment dominates the market due to rising adoption of digital technologies for diagnosis purposes among patients worldwide.


Global Disease Risk and Health Genetic Test Industry Outlook


Product Definition:


Disease risk and health genetic tests are used to determine a person's risk of developing certain diseases and conditions. The tests can also be used to help identify genes that may put a person at increased risk for health problems. Knowing about potential risks can allow people to make changes in their lifestyle or seek medical care that may help reduce their chances of developing a disease.


Celiac Disease:


Celiac disease (CD) is a chronic, progressive, and autoimmune disorder of the small intestine. The disease has two forms: non-infectious (celiac sprue) and infectious (celiac infection). Celiac sprue is an immune response to gluten that attacks the small intestine. CD affects 1 in every 133 people globally or around 3% of the global population.


Parkinson Disease:


Parkinson disease (PD) is a disorder of the central nervous system that affects the body’s motor systems, including the basal ganglia. PD is one of the most common neurodegenerative disorders and affects approximately 1 million people in America.


Application Insights:


The online application segment dominated the global disease risk and health genetic test market in 2017. This is attributed to factors such as rising prevalence of genetic diseases, increasing demand for carrier testing, and availability of a wide range of tests at low costs. For instance, 23andMe Testing Service offers over 150 different tests across seven categories- Health & Ancestry, Lifestyle & Relationships, DNA Test Kits ( paternity test), Genealogy & Family History, Research Studies- all available online free of charge to customers across the globe.


However, the offline application segment is expected to witness lucrative growth during the forecast period owing to factors such as an increase in awareness about these services among patients with a known history or family history associated with one or more genetic diseases; growing preference for face-to-face contact between healthcare professionals and patients; presence of dedicated centers providing disease risk information along with other related information regarding carrier screening.


Regional Analysis:


North America dominated the global disease risk and health genetic test market in 2017. The presence of a large number of players, high adoption rate for advanced technologies, and favorable reimbursement policies are some factors driving the regional market growth. Moreover, increasing awareness about these tests among patients is also expected to boost demand over the forecast period.


Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in research funding for diseases that can be prevented by early diagnosis will further drive this regional market over the next eight years.


Growth Factors:


  • Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily due to the changing lifestyles and dietary habits of people across the world. As a result, there is an increased demand for disease risk and health genetic tests that can help in early diagnosis and treatment of these conditions.
  • Growing awareness about personalized medicine: There is a growing awareness among people about the benefits of personalized medicine, which uses information about a person’s genes to tailor treatments accordingly. This has led to an increase in demand for disease risk and health genetic tests that can provide such information.
  • Advances in technology: The rapid advances in technology are helping to drive growth in the market for disease risk and health genetic tests. For instance, new sequencing technologies are making it possible to sequence entire genomes quickly and cheaply, thus providing more comprehensive information on a person’s genes than ever before.

Scope Of The Report

Report Attributes

Report Details

Report Title

Disease Risk and Health Genetic Test Market Research Report

By Type

Celiac Disease, Parkinson Disease, Alzheimer Disease, Other

By Application

Online, Offline

By Companies

23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

250

Number of Tables & Figures

175

Customization Available

Yes, the report can be customized as per your need.


Global Disease Risk and Health Genetic Test Market Report Segments:

The global Disease Risk and Health Genetic Test market is segmented on the basis of:

Types

Celiac Disease, Parkinson Disease, Alzheimer Disease, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Online, Offline

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. 23andMe
  2. MyHeritage
  3. LabCorp
  4. Myriad Genetics
  5. Ancestry.com
  6. Quest Diagnostics
  7. Gene By Gene
  8. DNA Diagnostics Center
  9. Invitae
  10. IntelliGenetics
  11. Ambry Genetics
  12. Living DNA
  13. EasyDNA
  14. Pathway Genomics
  15. Centrillion Technology
  16. Xcode
  17. Color Genomics
  18. Anglia DNA Services
  19. African Ancestry
  20. Canadian DNA Services
  21. DNA Family Check
  22. Alpha Biolaboratories
  23. Test Me DNA
  24. 23 Mofang
  25. Genetic Health
  26. DNA Services of America
  27. Shuwen Health Sciences
  28. Mapmygenome
  29. Full Genomes

Global Disease Risk and Health Genetic Test Market Overview


Highlights of The Disease Risk and Health Genetic Test Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Celiac Disease
    2. Parkinson Disease
    3. Alzheimer Disease
    4. Other
  1. By Application:

    1. Online
    2. Offline
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Disease Risk and Health Genetic Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Disease Risk and Health Genetic Test Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


A disease risk and health genetic test is a type of genetic test that can help identify whether an individual has a higher risk of developing certain diseases. This information can then be used to make decisions about lifestyle changes, such as diet and exercise, that may reduce the risk of developing these diseases.

Some of the key players operating in the disease risk and health genetic test market are 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes.

The disease risk and health genetic test market is expected to grow at a compound annual growth rate of 10.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Disease Risk and Health Genetic Test Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Disease Risk and Health Genetic Test Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Disease Risk and Health Genetic Test Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Disease Risk and Health Genetic Test Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Disease Risk and Health Genetic Test Market Size & Forecast, 2018-2028       4.5.1 Disease Risk and Health Genetic Test Market Size and Y-o-Y Growth       4.5.2 Disease Risk and Health Genetic Test Market Absolute $ Opportunity

Chapter 5 Global Disease Risk and Health Genetic Test Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Disease Risk and Health Genetic Test Market Size Forecast by Type
      5.2.1 Celiac Disease
      5.2.2 Parkinson Disease
      5.2.3 Alzheimer Disease
      5.2.4 Other
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Disease Risk and Health Genetic Test Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Disease Risk and Health Genetic Test Market Size Forecast by Applications
      6.2.1 Online
      6.2.2 Offline
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Disease Risk and Health Genetic Test Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Disease Risk and Health Genetic Test Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Disease Risk and Health Genetic Test Analysis and Forecast
   9.1 Introduction
   9.2 North America Disease Risk and Health Genetic Test Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Disease Risk and Health Genetic Test Market Size Forecast by Type
      9.6.1 Celiac Disease
      9.6.2 Parkinson Disease
      9.6.3 Alzheimer Disease
      9.6.4 Other
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Disease Risk and Health Genetic Test Market Size Forecast by Applications
      9.10.1 Online
      9.10.2 Offline
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Disease Risk and Health Genetic Test Analysis and Forecast
   10.1 Introduction
   10.2 Europe Disease Risk and Health Genetic Test Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Disease Risk and Health Genetic Test Market Size Forecast by Type
      10.6.1 Celiac Disease
      10.6.2 Parkinson Disease
      10.6.3 Alzheimer Disease
      10.6.4 Other
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Disease Risk and Health Genetic Test Market Size Forecast by Applications
      10.10.1 Online
      10.10.2 Offline
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Disease Risk and Health Genetic Test Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Disease Risk and Health Genetic Test Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Disease Risk and Health Genetic Test Market Size Forecast by Type
      11.6.1 Celiac Disease
      11.6.2 Parkinson Disease
      11.6.3 Alzheimer Disease
      11.6.4 Other
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Disease Risk and Health Genetic Test Market Size Forecast by Applications
      11.10.1 Online
      11.10.2 Offline
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Disease Risk and Health Genetic Test Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Disease Risk and Health Genetic Test Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Disease Risk and Health Genetic Test Market Size Forecast by Type
      12.6.1 Celiac Disease
      12.6.2 Parkinson Disease
      12.6.3 Alzheimer Disease
      12.6.4 Other
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Disease Risk and Health Genetic Test Market Size Forecast by Applications
      12.10.1 Online
      12.10.2 Offline
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Disease Risk and Health Genetic Test Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Disease Risk and Health Genetic Test Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Disease Risk and Health Genetic Test Market Size Forecast by Type
      13.6.1 Celiac Disease
      13.6.2 Parkinson Disease
      13.6.3 Alzheimer Disease
      13.6.4 Other
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Disease Risk and Health Genetic Test Market Size Forecast by Applications
      13.10.1 Online
      13.10.2 Offline
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Disease Risk and Health Genetic Test Market: Competitive Dashboard
   14.2 Global Disease Risk and Health Genetic Test Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 23andMe
      14.3.2 MyHeritage
      14.3.3 LabCorp
      14.3.4 Myriad Genetics
      14.3.5 Ancestry.com
      14.3.6 Quest Diagnostics
      14.3.7 Gene By Gene
      14.3.8 DNA Diagnostics Center
      14.3.9 Invitae
      14.3.10 IntelliGenetics
      14.3.11 Ambry Genetics
      14.3.12 Living DNA
      14.3.13 EasyDNA
      14.3.14 Pathway Genomics
      14.3.15 Centrillion Technology
      14.3.16 Xcode
      14.3.17 Color Genomics
      14.3.18 Anglia DNA Services
      14.3.19 African Ancestry
      14.3.20 Canadian DNA Services
      14.3.21 DNA Family Check
      14.3.22 Alpha Biolaboratories
      14.3.23 Test Me DNA
      14.3.24 23 Mofang
      14.3.25 Genetic Health
      14.3.26 DNA Services of America
      14.3.27 Shuwen Health Sciences
      14.3.28 Mapmygenome
      14.3.29 Full Genomes

Our Trusted Clients

Contact Us